Viewing Study NCT00841204


Ignite Creation Date: 2025-12-24 @ 9:08 PM
Ignite Modification Date: 2025-12-28 @ 2:15 PM
Study NCT ID: NCT00841204
Status: COMPLETED
Last Update Posted: 2017-12-26
First Post: 2009-02-10
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma
Sponsor: National Cancer Institute (NCI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: NCI-2009-01115
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators